Literature DB >> 15604309

Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation.

S C Agarwal1, I F Purcell, S S Furniss.   

Abstract

In patients who are refractory to medical treatment of hypertrophic cardiomyopathy, surgical myomectomy or percutaneous transluminal alcohol septal myocardial ablation (PTSMA) is appropriate, with both the procedures having comparable results. In PTSMA ethanol is selectively injected into septal arteries supplying the hypertrophied septal myocardium. The authors describe a case of apical myocardial injury caused by passage of ethanol into the distal left anterior descending artery through a septal collateral that developed after double bolus injection of ethanol. They advocate single bolus injection of alcohol to avoid this complication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15604309      PMCID: PMC1768640          DOI: 10.1136/hrt.2004.047993

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.

Authors:  W Ruzyłło; L Chojnowska; M Demkow; A Witkowski; B Kuśmierczyk-Droszcz; W Piotrowski; L Rausinska; M Karcz; L Małecka; W Rydlewska-Sadowska
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

2.  Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.

Authors:  S F Nagueh; S R Ommen; N M Lakkis; D Killip; W A Zoghbi; H V Schaff; G K Danielson; M A Quiñones; A J Tajik; W H Spencer
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

3.  Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.

Authors:  J X Qin; T Shiota; H M Lever; S R Kapadia; M Sitges; D N Rubin; F Bauer; N L Greenberg; D A Agler; J K Drinko; M Martin; E M Tuzcu; N G Smedira; B Lytle; J D Thomas
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

Review 4.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

5.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.

Authors:  H Seggewiss; U Gleichmann; L Faber; D Fassbender; H K Schmidt; S Strick
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

6.  Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?

Authors:  Kerstin Wustmann; Stephan Zbinden; Stephan Windecker; Bernhard Meier; Christian Seiler
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

7.  Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.

Authors:  L Faber; A Meissner; P Ziemssen; H Seggewiss
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

8.  Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions.

Authors:  Frank H Gietzen; Christian J Leuner; Ludger Obergassel; Claudia Strunk-Mueller; Horst Kuhn
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

9.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

10.  Experimental study of relationship between intracoronary alcohol injection and the size of resultant myocardial infarct.

Authors:  Zhan Quan Li; Tsung O Cheng; Li Liu; Yuan Zhe Jin; Ming Zhang; Ru Ming Guan; Long Yuan; Jian Hu; Wei Wei Zhang
Journal:  Int J Cardiol       Date:  2003-09       Impact factor: 4.164

  10 in total
  4 in total

1.  Septal myectomy after failed septal alcohol ablation.

Authors:  Eduard Quintana; Pietro Bajona; María José Arguis; Susanna Prat-González
Journal:  Ann Cardiothorac Surg       Date:  2017-07

2.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy in a patient with a chronic total occlusion of the right coronary artery: "beware of collateral damage".

Authors:  Quentin de Hemptinne; Fabien Picard; Philippe L L'Allier
Journal:  Cardiovasc Diagn Ther       Date:  2017-02

3.  Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy.

Authors:  Constantinos O'Mahony; Saidi A Mohiddin; Charles Knight
Journal:  Interv Cardiol       Date:  2014-04

Review 4.  Glue septal ablation: A promising alternative to alcohol septal ablation.

Authors:  Sercan Okutucu; Kudret Aytemir; Ali Oto
Journal:  JRSM Cardiovasc Dis       Date:  2016-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.